Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131 Article

Vogelbaum, Michael A, Hu, Chen, Peereboom, David M et al. (2015). Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131 . JOURNAL OF NEURO-ONCOLOGY, 124(3), 413-420. 10.1007/s11060-015-1845-7

Open Access International Collaboration

cited authors

  • Vogelbaum, Michael A; Hu, Chen; Peereboom, David M; Macdonald, David R; Giannini, Caterina; Suh, John H; Jenkins, Robert B; Laack, Nadia N; Brachman, David G; Shrieve, Dennis C; Souhami, Luis; Mehta, Minesh P

sustainable development goals

authors

publication date

  • September 1, 2015

webpage

published in

keywords

  • 1p/19q loss of heterozygosity
  • ADJUVANT PROCARBAZINE
  • CHEMOTHERAPY
  • CHROMOSOME ARMS 1P
  • Clinical Neurology
  • EUROPEAN-ORGANIZATION
  • LOMUSTINE
  • Life Sciences & Biomedicine
  • MGMT
  • MUTATIONS
  • Neurosciences & Neurology
  • Oligodendroglioma
  • Oncology
  • RADIOTHERAPY
  • RTOG
  • SURVIVAL
  • Science & Technology
  • TUMORS
  • Temozolomide
  • VINCRISTINE

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 413

end page

  • 420

volume

  • 124

issue

  • 3